他山之石 何以攻玉:从脑出血国际临床研究现状看我国的规范化治疗

自发性脑出血病死率和病残率较高,但缺乏有效的治疗策略.我国的脑出血相关研究与国际先进水平存在一定差距.近年国际上一系列临床研究从不同角度探讨脑出血的治疗方式,对我国脑出血研究和规范化治疗具有十分重要的参考价值.我国的脑出血临床治疗经验和研究成果要想走向世界,必须开展高质量的临床试验.四川大学华西医院神经外科正在开展IN...

How to use stones from other hills to polish our own jade: evaluating standardized treatment of intracerebral hemorrhage in China based on the current international clinical research

Spontaneous intracerebral hemorrhage (ICH) has high mortality and disability rate, but the effective treatment strategy is still lacking. There is a certain gap between the Chinese and the international ICH research. In recent years, a series of international clinical studies have explored the ICH treatment based on different strategies, which provides very important references for the research and standardized treatment of ICH in China. High-quality clinical trials are necessary to exchange between China and other countries. Department of Neurosurgery of West China Hospital, Sichuan University is carrying out Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial 3(INTERACT3) and preparing to carry out International Surgical Trial in Intracerebral Haemorrhage Ⅲ(STICH Ⅲ), hoping to promote the progress of ICH research in China.